000			01329 a2200433 4500
005			20250514001024.0
264		0	_c20010607
008			200106s 0 0 hun d
022			_a0030-6002
040			_aNLM _beng _cNLM
100	1		_aKovács, I
245	0	0	_a[Effect of ciprofibrate on the endothelial dysfunction of patients with combined dyslipidemia]. _h[electronic resource]
260			_bOrvosi hetilap _cApr 2001
300			_a775-9 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article
650	0	4	_aAdult
650	0	4	_aBlood Flow Velocity
650	0	4	_aCholesterol, HDL _xblood
650	0	4	_aCholesterol, LDL _xblood
650	0	4	_aClofibric Acid _xanalogs & derivatives
650	0	4	_aEndothelium, Vascular _xdrug effects
650	0	4	_aFemale
650	0	4	_aFibric Acids
650	0	4	_aHumans
650	0	4	_aHyperlipidemias _xblood
650	0	4	_aHypolipidemic Agents _xpharmacology
650	0	4	_aLinear Models
650	0	4	_aLipids _xblood
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aRetrospective Studies
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aTriglycerides _xblood
650	0	4	_aVasodilation
700	1		_aTarján, J
700	1		_aCsászár, A
773	0		_tOrvosi hetilap _gvol. 142 _gno. 15 _gp. 775-9
999			_c11299862 _d11299862